PMID- 30549356 OWN - NLM STAT- MEDLINE DCOM- 20200909 LR - 20200909 IS - 1097-0347 (Electronic) IS - 1043-3074 (Linking) VI - 41 IP - 2 DP - 2019 Feb TI - Serum matrix metalloproteinase 8 and tissue inhibitor of metalloproteinase 1: Potential markers for malignant transformation of recurrent respiratory papillomatosis and for prognosis of laryngeal cancer. PG - 309-314 LID - 10.1002/hed.25459 [doi] AB - BACKGROUND: Biomarkers that could predict malignant transformation of recurrent respiratory papillomatosis (RRP) would be useful in patient follow-up. We investigated whether serum matrix metalloproteinase 8 (MMP-8) and tissue inhibitor of metalloproteinase 1 (TIMP-1) could predict malignant transformation of RRP and whether they associate with survival in laryngeal squamous cell carcinoma (LSCC) without preexisting RRP. METHODS: We analyzed serum MMP-8 (S-MMP-8) and serum TIMP-1 (s-TIMP-1) in 114 patients: 55 were treated for RRP and 59 for LSCC without preexisting RRP. Five patients with RRP developed LSCC during follow-up. RESULTS: Elevated S-MMP-8 level in RRP was associated with malignant transformation (P = .01). Compared to patients with RRP, S-MMP-8 in patients with LSCC was significantly higher (P < .001). Increased S-TIMP-1 level in LSCC was associated with poor overall survival (P = .02) and recurrence-free survival (P = .05). CONCLUSION: In RRP, high S-MMP-8 may predict malignant transformation. In LSCC, elevated S-TIMP-1 is connected to poor survival. CI - (c) 2018 Wiley Periodicals, Inc. FAU - Pakkanen, Pihla P AU - Pakkanen PP AUID- ORCID: 0000-0002-0009-8146 AD - Department of Otorhinolaryngology-Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. FAU - Aaltonen, Leena-Maija AU - Aaltonen LM AD - Department of Otorhinolaryngology-Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. FAU - Sorsa, Timo A AU - Sorsa TA AD - Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland. AD - Department of Dental Medicine, Karolinska Institutet and Karolinska University Hospital, Huddinge, Stockholm, Sweden. FAU - Tervahartiala, Taina I AU - Tervahartiala TI AD - Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland. FAU - Hagstrom, Jaana K AU - Hagstrom JK AD - Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. FAU - Ilmarinen, Taru T AU - Ilmarinen TT AUID- ORCID: 0000-0001-8674-6417 AD - Department of Otorhinolaryngology-Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. LA - eng GR - Helsinki University Hospital/International PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20181214 PL - United States TA - Head Neck JT - Head & neck JID - 8902541 RN - 0 (Biomarkers) RN - 0 (Tissue Inhibitor of Metalloproteinase-1) RN - EC 3.4.24.34 (MMP8 protein, human) RN - EC 3.4.24.34 (Matrix Metalloproteinase 8) RN - Recurrent respiratory papillomatosis SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Biomarkers/blood MH - Carcinoma, Squamous Cell/*blood/etiology/mortality MH - Cell Transformation, Neoplastic MH - Female MH - Humans MH - Laryngeal Neoplasms/*blood/etiology/mortality MH - Male MH - Matrix Metalloproteinase 8/*blood MH - Middle Aged MH - Papillomavirus Infections/*blood/mortality/*pathology MH - Predictive Value of Tests MH - Respiratory Tract Infections/*blood/mortality/*pathology MH - Survival Rate MH - Tissue Inhibitor of Metalloproteinase-1/*blood OTO - NOTNLM OT - MMP-8 OT - TIMP-1 OT - biomarkers OT - laryngeal carcinoma OT - recurrent respiratory papilloma EDAT- 2018/12/15 06:00 MHDA- 2020/09/10 06:00 CRDT- 2018/12/15 06:00 PHST- 2018/01/07 00:00 [received] PHST- 2018/06/13 00:00 [revised] PHST- 2018/08/15 00:00 [accepted] PHST- 2018/12/15 06:00 [pubmed] PHST- 2020/09/10 06:00 [medline] PHST- 2018/12/15 06:00 [entrez] AID - 10.1002/hed.25459 [doi] PST - ppublish SO - Head Neck. 2019 Feb;41(2):309-314. doi: 10.1002/hed.25459. Epub 2018 Dec 14.